Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionChicago Capital, LLC
Latest Disclosed Ownership18,984 shares
Latest Disclosed Value $ 1,520,211
Chicago Capital, LLC reports 3.56% decrease in ownership of EW / Edwards Lifesciences Corporation

On April 23, 2026 - Chicago Capital, LLC filed a 13F-HR form disclosing ownership of 18,984 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,520,211 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 19,685 shares of Edwards Lifesciences Corporation. This represents a change in shares of -3.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-23 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 18,984 -701 -3.56 1,520 -9.42 0.0410
2026-01-26 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 19,685 0 0.00 1,678 9.67 0.0414
2025-10-22 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 19,685 -367 -1.83 1,531 -2.42 0.0377
2025-07-17 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 20,052 81 0.41 1,568 8.36 0.0387
2025-04-17 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 19,971 1,563 8.49 1,447 6.24 0.0409
2025-01-24 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 18,408 -83,763 -81.98 1,363 -79.80 0.0361
2024-10-18 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 102,171 -42,395 -29.33 6,742 -49.51 0.1872
2024-08-06 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 144,566 -2,159 -1.47 13,354 -4.76 0.3970
2024-04-15 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 146,725 -10,805 -6.86 14,021 16.73 0.4273
2024-01-22 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 157,530 -18,829 -10.68 12,012 -1.69 0.4325
2023-10-25 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 176,359 -3,063 -1.71 12,218 -27.81 0.5715
2023-07-20 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 179,422 -997 -0.55 16,925 13.39 0.7630
2023-04-18 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 180,419 -263,351 -59.34 14,926 -54.92 0.7426
2023-01-20 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 443,770 -47,241 -9.62 33,110 -18.39 1.8316
2022-10-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 491,011 -4,167 -0.84 40,572 -13.83 2.3466
2022-07-21 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 495,178 29,062 6.23 47,086 -14.19 2.6013
2022-04-21 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 466,116 15,255 3.38 54,871 -6.06 2.3617
2022-01-20 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 450,861 -6,205 -1.36 58,409 12.88 2.1750
2021-10-28 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 457,066 -3,393 -0.74 51,744 8.50 1.9626
2021-07-22 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 460,459 -875 -0.19 47,690 23.59 1.8637
2021-04-13 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 461,334 5,945 1.31 38,586 -7.12 1.6286
2021-01-25 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 455,389 107,585 30.93 41,545 49.65 1.8559
2020-10-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 347,804 30 0.01 27,762 15.51 1.4273
2020-07-29 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 347,774 233,180 203.48 24,035 11.20 1.3928
2020-04-21 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 114,594 -37,238 -24.53 21,615 -38.98 1.7430
2020-01-14 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 151,832 -3,743 -2.41 35,421 3.53 2.1611
2019-10-28 2019-09-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 155,575 -56,876 -26.77 34,212 -12.83 2.2913
2019-07-11 2019-06-30 13F EDWARDS LIFESCIENCES COMMON 28176E108 212,451 7,429 3.62 39,248 0.05 2.5107
2019-04-23 2019-03-31 13F EDWARDS LIFESCIENCES COMMON 28176E108 205,022 -4,424 -2.11 39,227 22.27 2.6664
2019-02-11 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 209,446 -1,444 -0.68 32,081 -12.62 2.6161
2018-11-02 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 210,890 24,131 12.92 36,716 35.05 2.5399
2018-07-19 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 186,759 59,392 46.63 27,187 52.99 2.1919
2018-05-09 2018-03-31 13F Edwards Lifesciences COM 28176E108 127,367 127,367 17,770 2.3712
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.